TRERF1: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
imported>Bibcode Bot m (Adding 0 arxiv eprint(s), 1 bibcode(s) and 0 doi(s). Did it miss something? Report bugs, errors, and suggestions at User talk:Bibcode Bot) |
||
| Line 24: | Line 24: | ||
*{{cite journal |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} | *{{cite journal |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} | ||
*{{cite journal |vauthors=Gizard F, Teissier E, Dufort I, etal |title=The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells. |journal=J. Mol. Endocrinol. |volume=32 |issue= 2 |pages= 557–69 |year= 2005 |pmid= 15072559 |doi=10.1677/jme.0.0320557 }} | *{{cite journal |vauthors=Gizard F, Teissier E, Dufort I, etal |title=The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells. |journal=J. Mol. Endocrinol. |volume=32 |issue= 2 |pages= 557–69 |year= 2005 |pmid= 15072559 |doi=10.1677/jme.0.0320557 }} | ||
*{{cite journal |vauthors=Beausoleil SA, Jedrychowski M, Schwartz D, etal |title=Large-scale characterization of HeLa cell nuclear phosphoproteins. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 33 |pages= 12130–5 |year= 2004 |pmid= 15302935 |doi= 10.1073/pnas.0404720101 | pmc=514446 }} | *{{cite journal |vauthors=Beausoleil SA, Jedrychowski M, Schwartz D, etal |title=Large-scale characterization of HeLa cell nuclear phosphoproteins. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 33 |pages= 12130–5 |year= 2004 |pmid= 15302935 |doi= 10.1073/pnas.0404720101 | pmc=514446 |bibcode=2004PNAS..10112130B }} | ||
*{{cite journal |vauthors=Gizard F, Robillard R, Barbier O, etal |title=TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1. |journal=Mol. Cell. Biol. |volume=25 |issue= 11 |pages= 4335–48 |year= 2005 |pmid= 15899840 |doi= 10.1128/MCB.25.11.4335-4348.2005 | pmc=1140623 }} | *{{cite journal |vauthors=Gizard F, Robillard R, Barbier O, etal |title=TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1. |journal=Mol. Cell. Biol. |volume=25 |issue= 11 |pages= 4335–48 |year= 2005 |pmid= 15899840 |doi= 10.1128/MCB.25.11.4335-4348.2005 | pmc=1140623 }} | ||
*{{cite journal |vauthors=Gizard F, Robillard R, Gross B, etal |title=TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. |journal=Mol. Cell. Biol. |volume=26 |issue= 20 |pages= 7632–44 |year= 2006 |pmid= 17015480 |doi= 10.1128/MCB.00326-06 | pmc=1636875 }} | *{{cite journal |vauthors=Gizard F, Robillard R, Gross B, etal |title=TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. |journal=Mol. Cell. Biol. |volume=26 |issue= 20 |pages= 7632–44 |year= 2006 |pmid= 17015480 |doi= 10.1128/MCB.00326-06 | pmc=1636875 }} | ||
Latest revision as of 19:16, 26 June 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
Transcriptional-regulating factor 1 is a protein that in humans is encoded by the TRERF1 gene.[1][2]
This gene encodes a zinc-finger transcriptional regulating protein that interacts with CBP/p300 to regulate the human gene CYP11A1.[2]
Interactions
TRERF1 has been shown to interact with Steroidogenic factor 1,[3] EP300[1] and CREB-binding protein.[1]
References
- ↑ 1.0 1.1 1.2 Gizard F, Lavallee B, DeWitte F, Hum DW (Sep 2001). "A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression". J Biol Chem. 276 (36): 33881–92. doi:10.1074/jbc.M100113200. PMID 11349124.
- ↑ 2.0 2.1 "Entrez Gene: TRERF1 transcriptional regulating factor 1".
- ↑ Gizard, Florence; Lavallee Bernard; DeWitte Frederique; Teissier Elisabeth; Staels Bart; Hum Dean W (Oct 2002). "The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells". J. Biol. Chem. United States. 277 (42): 39144–55. doi:10.1074/jbc.M205786200. ISSN 0021-9258. PMID 12101186.
Further reading
- Dorssers LC, Veldscholte J (1997). "Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells". Int. J. Cancer. 72 (4): 700–5. doi:10.1002/(SICI)1097-0215(19970807)72:4<700::AID-IJC24>3.0.CO;2-D. PMID 9259413.
- Gizard F, Lavallee B, DeWitte F, et al. (2002). "The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells". J. Biol. Chem. 277 (42): 39144–55. doi:10.1074/jbc.M205786200. PMID 12101186.
- Gizard F, El-Alfy M, Duguay Y, et al. (2003). "Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expression". Endocr. Res. 28 (4): 559–74. doi:10.1081/ERC-120016841. PMID 12530663.
- Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6". Nature. 425 (6960): 805–11. doi:10.1038/nature02055. PMID 14574404.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Gizard F, Teissier E, Dufort I, et al. (2005). "The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells". J. Mol. Endocrinol. 32 (2): 557–69. doi:10.1677/jme.0.0320557. PMID 15072559.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. Bibcode:2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Gizard F, Robillard R, Barbier O, et al. (2005). "TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1". Mol. Cell. Biol. 25 (11): 4335–48. doi:10.1128/MCB.25.11.4335-4348.2005. PMC 1140623. PMID 15899840.
- Gizard F, Robillard R, Gross B, et al. (2006). "TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone". Mol. Cell. Biol. 26 (20): 7632–44. doi:10.1128/MCB.00326-06. PMC 1636875. PMID 17015480.
 | This article on a gene on human chromosome 6 is a stub. You can help Wikipedia by expanding it. |